Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Feature

2nd Annual Specialty Pharmaceuticals Global Summit

Posted on: 25 Apr 06

Summary

Specialty Pharma transformations and venture investments have continued to grow at an unprecedented pace. The 2006 meeting is an elite opportunity for Big Pharma, Biotech, and Drug Delivery to network with the industry's fastest growing Specialty Pharma companies and discover what makes them so attractive as a partner.

Specialty Pharma transformations and venture investments have continued to grow at an unprecedented pace. The 2006 meeting is an elite opportunity for Big Pharma, Biotech, and Drug Delivery to network with the industry's fastest growing Specialty Pharma companies and discover what makes them so attractive as a partner.

State of the Industry Panel Discussions:

  • Specialty Pharma Awareness to Attract Big Pharma Portfolio Divestitures
  • Therapeutic Area Specialization: What Does the Future Hold and What are the Unmet Areas for Lucrative Opportunities?
  • Partnering in Specialty Pharma: A Novel & Profitable Business Model for the Pharmaceutical Industry
  • What Venture Capitalists Want in a Specialty Pharma Investment & How Long Will They Continue to Invest in Specialty Pharma?

DISTINGUISHED BOARD OF ADVISORS

Dan Marino, MSc
Executive Editorial Director
DRUG DELIVERY TECHNOLOGY & SPECIALTY PHARMA MAGAZINES
Cindy H. Dubin
Editor-in-Chief
SPECIALTY PHARMA MAGAZINE
Woody Bryan, Ph.D.
Vice President, Business Development
SUPERNUS PHARMACEUTICALS, INC.
Vik Seoni, MBA
Senior Director, Business Development
ENDO PHARMACEUTICALS
Howard S. Wachtler
CEO
ACTINIUM PHARMACEUTICALS
Kathleen Williams, Ph.D., JD
Co-Chair Life Sciences Practice
EDWARDS ANGELL PALMER & DODGE LLP
Christine C. Mayer
VP, Global Business Development & Licensing
BIOVAIL PHARMACEUTICALS, INC.
Mark Horn
Director, Finance and R&D Portfolio Management
WYETH
 

PARTICIPANTS INCLUDE:

  • Abeille Pharmaceuticals, Inc.
  • Actinium Pharmaceuticals
  • A.M. Pappas & Associates
  • Analytica International
  • Biovail Pharmaceuticals, Inc.
  • Bristol-Myers Squibb
  • Daiichi Medical Research, Inc.
  • Davidson, Davidson & Kappel, LLC
  • Domain Associates, LLC
  • Edwards Angell Palmer & Dodge LLP
  • Elan Pharmaceuticals
  • Endo Pharmaceuticals, Inc
  • Integrium
  • Javelin Pharmaceuticals
  • King Pharmaceuticals, Inc.
  • Millennium Pharmaceuticals
  • Nektar Therapeutics
  • Novartis Pharmaceuticals Corporation
  • Patrin Pharma
  • Penwest Pharmaceuticals
  • Provectus Pharmaceuticals, Inc.
  • Recombinant Capital, Inc.
  • Supernus Pharmaceuticals, Inc.
  • Synergy Advisors, LLC
  • Techno Venture Management
  • Wyeth

Ed Drilon

Last updated on: 27/08/2010 11:40:18

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.